⭐️5 / 5
Rating
🙌1
Ratings
📼1 sc
Content
📦w/o updates
Updates frequency
🗣❌ unsupported
Your locale

All Versions of DIRE

1.2

March 31, 2022

Updates for iOS 15 Thank you for supporting DIRE!

1.1

February 24, 2017

This app has been updated by Apple to display the Apple Watch app icon. Added a confirmation screen to initial Terms and Conditions
More

1.0

January 17, 2017

Price History of DIRE

Description of DIRE

The DIRE Score is a tool that can be used to aid clinicians in their decision-making process when considering prescribing opioids for chronic non-malignant pain. Using the DIRE Score, the clinician rates seven factors each on a scale of 1, 2 or 3 with 1 being the least favorable or highest risk for prescribing opioids and 3 being the most compelling or lowest risk for prescribing. The seven DIRE factors are: Diagnosis, Intractability, Risk (there are four risk factors—psychological and chemical health, patient reliability and social support/life roles) and Efficacy. Adding the scores for these seven factors gives a total of 7 – 21. A score of 7-13 was predictive of a low probability of success when prescribing opioids; whereas a score of 14-21 was more likely to be associated with a successful prescribing process and outcome. The DIRE Score does not take into account medical risk factors for opioid prescribing such as comorbid medical conditions (chronic obstructive lung disease, sleep apnea, concomitant use of benzodiazepines, etc.). The clinician should understand that active use of illicit drugs, drug diversion and other aberrant behaviors is incompatible with ongoing opioid prescribing no matter what the DIRE Score may be. The DIRE Score is not meant to be a substitute for sound clinical judgment in the context of any individual patient. This App is meant for informational use only, and is not intended to aid in the diagnosis, treatment or prevention of disease. Decisions about prescribing are solely the responsibility of the licensed prescriber.
Show less

DIRE: FAQ

Is DIRE compatible with the iPad?

Yes, you can use the DIRE app on iPad devices.
The DIRE app was created by Riemenrade Studios LLC.
Currently, DIRE supports iOS 12.0 or later.
The overall user rating of DIRE is 5.0.
The App Genre Of The Dire App Is Medical.
The latest DIRE version released is 1.2.
The date of the latest DIRE update is July 1, 2024.
DIRE became publicly available on February 5, 2023.
The content advisory rating for DIRE is Riemenrade Studios LLC.
DIRE is now available to use in American English.
Sorry, DIRE is not part of Apple Arcade.
No, DIRE is not eligible for in-app purchases.
Unfortunately, DIRE is not fully compatible with Apple Vision Pro.

Screenshot of DIRE

iphone
ipad

Alternatives to DIRE

Reviews of DIRE

  • Simple and to the point

    Great app. Very useful .
  • Great tool

    This is a great app. It's easy to use and intuitive. Really helps as a guideline when considering opioids. And it's the only tool that isn't a a self report questionnaire filled out by patients, so the kind of bias in that sort of tool just isn't there.
  • Easy to use opioid screening tool!

    I have used the DIRE Score and taught about it for years. This app makes it simple, intuitive and lightening fast to calculate a score for patients you know. It is as handy as your phone. I love the red yellow and green buttons that, like traffic signals, guide the clinicians' go no-go decision about long-term prescribing.